Variant Pharmaceuticals Has a New Name - ZyVersa Therapeutics, Inc.
Professor of Medicine, David Geffen School of Medicine, UCLA
Chief, Division of Nephrology and Hypertension, Harbor-UCLA Medical Center
Program Director, Nephrology Fellowship Training Program at Harbor-UCLA Medical Center
Dr. Adler is Chief and the Training Program Director for Nephrology at Harbor-UCLA Medical Center, and Professor of Medicine at the David Geffen School of Medicine at UCLA. Her areas of particular expertise include diabetic kidney disease, glomerular disease, hemo-and peritoneal dialysis. She has published more than 100 peer-reviewed journal articles, and more than 100 reviews, editorials and abstracts.
Some of her key contributions are:
Co-Director, Clinical Nephrology, New York-Presbyterian Hospital/Columbia University Medical Center
Professor of Clinical Medicine and Director of the Glomerular Kidney Disease Center, Columbia University College of Physicians and Surgeons
Dr. Appel has been a tenured Professor of Medicine at Columbia University College of Physicians and Surgeons since 1989. He received his undergraduate BA from Cornell University graduating in three years with distinction in all subjects and as a member of phi beta kappa. He received his medical degree from Albert Einstein College of Medicine, NY in 1972, where he was elected to the medical honor society Alpha Omega Alpha. He completed his internship and residency in Internal Medicine at Columbia Presbyterian Medical Center. He then completed Fellowships in Nephrology at both Columbia-Presbyterian Med. Ctr. (1975 - 1976) and at Yale-New Haven Medical Center, New Haven, Connecticut (1976 - 1978). He has spent the rest of his career at Columbia University.
Dr. Appel has served as an oﬃcer and President of The NY Society of Nephrology. He has served on the Medical Advisory Board and as the Chairman of the Research Committee of the National Kidney Foundation (NKF) of NY-NJ and The Kidney and Urology Foundation of America, and as Chair of the Council of Glomerulonephritis of the NKF of the United States.
Dr. Appel has served on the editorial board of a number of journals including the Clinical Journal of the American Society of Nephrology, Clinical Nephrology, and the editorial board of Up-To-Date. He has been the director of a number of educational courses including The Columbia U Internal Medicine Course in NYC, Renal Biopsy in Medical Diseases of the Kidney in NYC, and for many years had directed the annual course in The Treatment of Glomerular Diseases at the American Society of Nephrology meetings (1998 - 2010).
Dr Appel has authored and co-authored over 325 peer-reviewed articles and book chapters. He has received numerous awards including the Albert Douglas Award of the Medical Society of NY State for excellence in clinical teaching, The Lester Honig Award of the NY-NJ Kidney Foundation, the Distinguished Service Award of the Nephcure Foundation, and twice the Teacher of the Year Award by Columbia University’s medical school classes. At any given time, Dr. Appel is the PI or Co-PI on 15-20 grants at Columbia U, including major NIH grants through the NEPTUNE Study and CURE GN Study. He was awarded The Donald Seldin Award for life-time achievement by the National Kidney Foundation of the US in 2012. His career has been devoted to the care and welfare of patients with glomerulonephritis, lupus, and the nephrotic syndrome.
Chief, Division of Nephrology and Hypertension
Director, Peggy and Harold Katz Family Drug Discovery Center
University of Miami Miller School of Medicine
Dr. Fornoni received her medical degree from the School of Medicine at the University of Pavia, Italy. She subsequently obtained a Ph.D. Degree in Medical Pharmacology at the same University.
She is currently tenured Professor of Medicine and Molecular and Cellular Pharmacology at the University of Miami Miller School of Medicine. She is Chief of the Division of Nephrology and Hypertension and she is the Director of the Peggy and Harold Katz Drug Discovery Center at the University of Miami. She is Co-Director of Novel Methods for the Clinical and Translational Science Institute (CTSI) and Associate Director of the MD PhD program at the same Institution. Dr. Fornoni has gained experience in drug development as Global Head of Discovery in Cardiovascular and Metabolism at Hoffman-La Roche in Basel. She is currently the Vice President and Chief Scientific Officer of L&F Health LLC, a small start-up company focused on finding a cure for patients affected by chronic kidney diseases.
As a physician-scientist who has maintained a resolutely focused research program that has provided novel and seminal contributions to the understanding of the pathogenesis of kidney disease, Dr. Fornoni has conducted research supported by grants from National Institutes of Health, industry and private foundations. She has received prestigious awards, serves on the editorial board of Diabetes and other journals, has been invited to present at national and international meetings in five different continents, and has served as visiting professor at more than 25 academic institutions. Dr. Fornoni serves as grant reviewer for NIH, DOD, ADA, AHA, UK-diabetes and the Italian Ministry of Health. Her contributions have been published in high impact journals: Journal of Clinical Investigation, NEJM, Nature Medicine, Science Translational Medicine, Journal of Biological Chemistry, Diabetes, Kidney International and the Journal of the American Society of Nephrology among others.
Professor, Department of Pediatrics, University of Michigan
Director, Kidney Research Network Coordinating Center
Dr. Gipson is a Nephrologist and Epidemiologist and manages a research team with a focus to develop, design, and conduct clinical trials for adults and children with kidney disease and improve patient outcomes. She is also a practicing Pediatric Nephrologist at the University of Michigan.
Dr. Gipson graduated from Indiana University School of Medicine in 1989, and she completed pediatric residency at Indiana University Medical Center in 1992, followed by a year as chief resident in 1993. She completed a fellowship in Pediatric Nephrology at Seattle Children's Hospital/University of Washington School of Medicine in 1998 and a Master’s in Epidemiology from University of Washington in 1998.
Chief Medical Officer, ZyVersa Therapeutics
Dr. Guzman received his bachelor's degree in biology in 1971 from St Peter's College in Jersey City, his medical degree from the University of Puerto Rico School of Medicine in 1975 and his interventional cardiology fellowship at The Johns Hopkins Hospital in Baltimore in 1980 where then he joined the staff for the next 3 years. His duties included patient care, teaching, and both clinical and basic science research. Dr. Guzman became the Assistant Director of the cardiac catheterization lab, and Co-director of the permanent pacemaker lab at The Johns Hopkins Hospital, and also Co-director of the cardiac catheterization lab at Baltimore City Hospital. He has over 30 articles in peer reviewed journals and many abstracts, some of them presented in national meetings including the American Heart Association and the American College of Cardiology. While at Hopkins, Dr. Guzman became a Fellow of the American Heart Association Council on Clinical Cardiology, a member of the North American Society of Pacing and Electrophysiology, and a Fellow of The American College of Cardiology.
Dr. Guzman came to South Florida in 1983, and established a private practice in Cardiology. In 1987 he designed and became the Director of the Cardiac Catheterization Laboratory at Boca Raton Community Hospital (now Boca Regional Hospital) and a Fellow of the Society for Cardiac Angiography and Interventions. He then became the Associate Director of the Cardiac catheterization Laboratory at North Ridge Medical Center.
Dr. Guzman is a past president of the Caducean Society of Greater Fort Lauderdale, a past Chief of the Department of Cardiovascular and Pulmonary Diseases at North Ridge Medical Center, and a member of The North Ridge Medical Center Board. Dr. Guzman was a managing partner of Cardiology Associates of Fort Lauderdale, and is currently a member of The Broward County Medical Association. Dr. Guzman has been in the private practice of Medicine/ Cardiology in South Florida for 32 years.
Principal and founder at Orphan Solutions and Haffner Associates, LLC
Former Director of the Office of Orphan Products Development of the FDA
Retired Rear Admiral in the US Public Health Service
Dr. Haffner was the Director of the Office of Orphan Products Development at the Food and Drug Administration for 20+ years. In addition to assisting in the development of more than 300 products in the US, she is credited with assisting in the development of programs in Japan, the European Union, Australia, and beyond.
She founded Haffner Associates in 2009 in order to continue to apply her extensive experience in development of orphan products by working with small to large biotech/pharmaceutical companies, patient advocacy groups, and government agencies. Dr. Haffner also serves as an expert advisor and board member to companies throughout the world.
Trained as an internist and hematologist, Dr. Haffner graduated from the George Washington University School of Medicine and did further training at the Columbia University School of Medicine and the Albert Einstein College of Medicine, in New York City. She received her Masters of Public Health from the Johns Hopkins Bloomberg School of Public Health in Baltimore.
Following her tenure at FDA and prior to forming Haffner Associates, Dr. Haffner served as Executive Director, Global Regulatory Intelligence and Policy for two years at Amgen, the largest biotech company in the world.
Dr. Haffner has worked in the Washington, DC metropolitan area for more than 30 years. She has seen many changes in the regulatory environment during that period of time and is both sensitive and knowledgeable about politics and the political landscape. She knows “FDA think” and maintains close ties with her friends and colleagues in the agency.
Clinical Director, Penn Glomerular Disease Center
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Dr. Hogan is Clinical Director of the Penn Glomerular Disease Center, and Assistant Professor of Medicine, Division of Nephrology, at the Hospital of the University of Pennsylvania in Philadelphia.
He received his medical education at the University of Pennsylvania School of Medicine in Philadelphia, followed by a residency in internal medicine at the Hospital of the University of Pennsylvania, and Nephrology Fellowship at New York-Presbyterian/Columbia University Medical Center. He then completed a fellowship in glomerular diseases at the Columbia University Glomerular Center.
His clinical expertise includes glomerular diseases, kidney disease in cancer patients, vasculitis, lupus nephritis, nephrotic syndrome, and proteinuria. Dr. Hogan has published more than 15 papers in peer reviewed medical journals.
Dr. Hogan is a member of the American Society of Nephrology, the Cure Glomerulopathy Network, and NephCure Kidney International.